155 related articles for article (PubMed ID: 12009846)
1. Antifibrotic role of inducible nitric oxide synthase.
Ferrini MG; Vernet D; Magee TR; Shahed A; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 May; 6(3):283-94. PubMed ID: 12009846
[TBL] [Abstract][Full Text] [Related]
2. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
[TBL] [Abstract][Full Text] [Related]
3. Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model.
Vernet D; Ferrini MG; Valente EG; Magee TR; Bou-Gharios G; Rajfer J; Gonzalez-Cadavid NF
Nitric Oxide; 2002 Dec; 7(4):262-76. PubMed ID: 12446175
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.
Davila HH; Magee TR; Vernet D; Rajfer J; Gonzalez-Cadavid NF
Biol Reprod; 2004 Nov; 71(5):1568-77. PubMed ID: 15240426
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
Bivalacqua TJ; Champion HC; Leungwattanakij S; Yang DY; Hyun JS; Abdel-Mageed AB; Sikka SC; Kadowitz PJ; Hellstrom WJ
J Androl; 2001; 22(3):497-506. PubMed ID: 11330651
[TBL] [Abstract][Full Text] [Related]
6. Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease.
Davila HH; Ferrini MG; Rajfer J; Gonzalez-Cadavid NF
BJU Int; 2003 Jun; 91(9):830-8. PubMed ID: 12780843
[TBL] [Abstract][Full Text] [Related]
7. Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media.
Ferrini MG; Davila HH; Valente EG; Gonzalez-Cadavid NF; Rajfer J
Cardiovasc Res; 2004 Mar; 61(4):796-805. PubMed ID: 14985077
[TBL] [Abstract][Full Text] [Related]
8. Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis.
Ferrini M; Magee TR; Vernet D; Rajfer J; González-Cadavid NF
Biol Reprod; 2001 Mar; 64(3):974-82. PubMed ID: 11207215
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
[TBL] [Abstract][Full Text] [Related]
10. A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression.
Bivalacqua TJ; Diner EK; Novak TE; Vohra Y; Sikka SC; Champion HC; Kadowitz PJ; Hellstrom WJ
J Urol; 2000 Jun; 163(6):1992-8. PubMed ID: 10799245
[TBL] [Abstract][Full Text] [Related]
11. Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis.
Ferrini MG; Nolazco G; Vernet D; Gonzalez-Cadavid NF; Berman J
Fertil Steril; 2006 Oct; 86(4 Suppl):1152-63. PubMed ID: 16978624
[TBL] [Abstract][Full Text] [Related]
12. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes.
Ferrini MG; Rivera S; Moon J; Vernet D; Rajfer J; Gonzalez-Cadavid NF
J Sex Med; 2010 Sep; 7(9):3033-44. PubMed ID: 20626593
[TBL] [Abstract][Full Text] [Related]
13. Experimental models of Peyronie's disease. Implications for new therapies.
Gonzalez-Cadavid NF; Rajfer J
J Sex Med; 2009 Feb; 6(2):303-13. PubMed ID: 19138365
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.
Gonzalez-Cadavid NF; Rajfer J
Nat Rev Urol; 2010 Apr; 7(4):215-21. PubMed ID: 20212516
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase activity prevents liver recovery in rat thioacetamide-induced fibrosis reversal.
Lukivskaya O; Patsenker E; Lis R; Buko VU
Eur J Clin Invest; 2008 May; 38(5):317-25. PubMed ID: 18380797
[TBL] [Abstract][Full Text] [Related]
16. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.
Yue G; Lai PS; Yin K; Sun FF; Nagele RG; Liu X; Linask KK; Wang C; Lin KT; Wong PY
J Pharmacol Exp Ther; 2001 Jun; 297(3):915-25. PubMed ID: 11356911
[TBL] [Abstract][Full Text] [Related]
17. Rapid NOS-1-derived nitric oxide and peroxynitrite formation act as signaling agents for inducible NOS-2 expression in vascular smooth muscle cells.
Scheschowitsch K; de Moraes JA; Sordi R; Barja-Fidalgo C; Assreuy J
Pharmacol Res; 2015 Oct; 100():73-84. PubMed ID: 26253183
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
[TBL] [Abstract][Full Text] [Related]
19. Cognitive deficits after systemic induction of inducible nitric oxide synthase: a randomised trial in rats.
Eckel B; Ohl F; Bogdanski R; Kochs EF; Blobner M
Eur J Anaesthesiol; 2011 Sep; 28(9):655-63. PubMed ID: 21743335
[TBL] [Abstract][Full Text] [Related]
20. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E
Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
